Kushtha ↔ Psoriasis, Leprosy, and Dermatophytosis

Per the source material, "the mistranslation [of kushtha as leprosy] has done real harm" -- kushtha's eighteen-type taxonomy maps with real morphological precision onto psoriasis, tinea, and true leprosy, and the classical safety rule ("any suspicious hypopigmented, anaesthetic patch must be tested for sensory loss") correctly anticipates the single highest-stakes distinction in the differential. But shodhana-based treatment has no antifungal or antimycobacterial action.

IN PLAIN LANGUAGE

"Kushtha" is Ayurveda's broad term for chronic skin disease, and its eighteen-type classification actually captures real, accurate visual descriptions of several different modern skin conditions -- psoriasis, ringworm (tinea), and leprosy among them. But because these are biologically completely different diseases (an autoimmune condition, a fungal infection, and a bacterial infection), no single treatment approach works for all of them -- and Ayurvedic texts themselves insist on a specific safety check (testing for numbness) before treating any pale patch as ordinary skin disease, because that specific test is how leprosy gets caught early.

Classical Ayurvedic teaching about skin disease correctly separates out different visual patterns and, notably, has a specific rule for catching leprosy early. But because it groups an autoimmune disease, a fungal infection, and a bacterial infection under one umbrella term, treating all of them the same way withholds the antifungal medicine or the specific multidrug leprosy treatment each actually needs. Modern medicine identifies which specific disease is present through testing and offers a treatment matched to the actual cause.

WHEN TO SEEK CARE

See a doctor if any skin patch has numbness or loss of sensation, if a ring-shaped itchy rash doesn't improve after two weeks of treatment, if a skin lesion bleeds, ulcerates, or won't heal, or if a skin eruption comes with fever or is in a child who has been in contact with someone diagnosed with leprosy.

🔴 REFER IMMEDIATELY

Any hypopigmented or erythematous patch with sensory loss (numbness, loss of pain/temperature sensation) -- treat as leprosy until proven otherwise
Any suspected fungal skin lesion not improving after two weeks of any treatment
Rapidly spreading skin lesion with systemic symptoms (fever, malaise)
Skin lesions with mucosal or nail involvement suggesting a bullous or autoimmune disease requiring biopsy
Children or contacts of a diagnosed leprosy case
Any skin lesion that ulcerates, bleeds spontaneously, or fails to heal (possible malignancy)
Any patch with sensory loss
Any lesion not improving after two weeks of topical treatment
Any lesion in a child or a contact of a known leprosy case
Systemic symptoms accompanying a skin eruption
Any lesion suggestive of malignancy

Never do this

Do not treat a hypopigmented or anaesthetic patch as ordinary kushtha without first testing for sensory loss -- untreated leprosy causes progressive nerve damage and permits ongoing transmission, and multidrug therapy, not shodhana, is the required treatment. Do not treat a spreading, ring-shaped, itchy lesion (dadru/tinea) with shodhana alone without an antifungal -- fungal infection will persist and continue to spread on the body and to household contacts regardless of purification therapy. Do not delay skin biopsy for a chronic lesion that ulcerates, bleeds, or fails to heal on the assumption that it is a kushtha type -- skin malignancy requires prompt diagnosis.

🟢 SUITABLE FOR ROUTINE / COLLABORATIVE CARE

AYURVEDA SCOPE

Shodhana-based management (vamana, virechana, raktamokshana as indicated) and supportive formulations (Khadirarishta, Panchatikta Ghrita, Mahatiktaka Kashaya) for classical presentations of chronic inflammatory skin disease consistent with psoriasis, once tinea and leprosy have been specifically excluded by modern testing.

MODERN MEDICINE SCOPE

KOH microscopy or fungal culture for suspected tinea; skin smear/biopsy and WHO classification for suspected leprosy; topical/systemic antifungals; multidrug therapy for leprosy; topical/phototherapy/biologic treatment for psoriasis based on severity.

COLLABORATIVE SCOPE

Sensory testing of any hypopigmented or anaesthetic patch performed as a mandatory first step before any kushtha treatment is started, with dermatology referral for confirmation and appropriate antifungal or antimycobacterial treatment when indicated, and shodhana-based support continued alongside modern treatment for the inflammatory component where appropriate.

Sign in to read the full comparison

The plain-language summary and safety guidance above are free for everyone. The 10-dimension scholarly comparison needs an account.